BiotechTube
Home/Rona Therapeutics/Stella (Yibin) Shi
S(

Stella (Yibin) Shi

Chief Executive Officer, Founder

Rona Therapeutics

Therapeutic Areas

CardiovascularMetabolicNeurologicalHepatic

Rona Therapeutics Pipeline

DrugIndicationPhase
RN0191Cardiovascular Disease (PCSK9)Phase 1
RN0361Hypertriglyceridemia (ApoC3)Phase 1
RN3161Obesity (INHBE)IND-Enabling
RN5681ASCVD (PCSK9-Lp(a))Preclinical
RN1871Hypertension (AGT)Phase 1

Leadership Team at Rona Therapeutics

AM
Alex M. DePaoli, M.D.
Chief Medical Officer and Executive Vice President of Translational Research
JH
Jinyu Huang, Ph.D.
Senior Vice President of Chemistry
LP
Ling Pan, Ph.D.
Executive Vice President of Discovery & Research
J(
Joshua (Jianhua) Yu, Ph.D.
Vice President of CMC
J(
Jasper (Zhuocheng) Tu
Vice President of Finance and Corporate Development
View full Rona Therapeutics profile